Katrin Manda

Dr. Katrin Manda

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Franz RödelFranz Rödel
Franz Rödel
Benjamin FreyBenjamin Frey
Benjamin Frey
UGU. Gaipl
U. Gaipl
LKL. Keilholz
L. Keilholz
CFC. Fournier
C. Fournier
CRC. Rodel
C. Rodel
During the last decade, a multitude of experimental evidence has accumulated showing that low-dose radiation therapy (single dose 0.5-1 Gy) functionally modulates a variety of inflammatory processes and cellular compounds including endothelial (EC), mononuclear (PBMC) and polymorphonuclear (PMN) cells, respectively. These modulations comprise a hampered leukocyte adhesion to EC, induction of apoptosis, a reduced activity of the inducible nitric oxide synthase, and a lowered oxidative burst in macrophages. Moreover, irradiation with a single dose between 0.5-0.7 Gy has been shown to induce the expression of X-chromosome linked inhibitor of apoptosis and transforming growth factor beta 1, to reduce the expression of E-selectin and L-selectin from EC and PBMC, and to hamper secretion of Interleukin-1, or chemokine CCL20 from macrophages and PMN. Notably, a common feature of most of these responses is that they display discontinuous or biphasic dose dependencies, shared with "non-targeted" effects of low-dose irradiation exposure like the bystander response and hyper-radiosensitivity. Thus, the purpose of the present review is to discuss recent developments in the understanding of low-dose irradiation immune modulating properties with special emphasis on discontinuous dose response relationships.

1 January 2012 in Frontiers in Oncology
Verified
Journal Article
Open access
KMKatrin Manda
Katrin Manda
AGAnnegret Glasow
Annegret Glasow
DPDaniel Paape
Daniel Paape
GHGuido Hildebrandt
Guido Hildebrandt
Dendritic cells (DCs), as professional antigen-presenting cells, are members of the innate immune system and function as key players during the induction phase of adaptive immune responses. Uptake, processing, and presentation of antigens direct the outcome toward either tolerance or immunity. The cells of the immune system are among the most highly radiosensitive cells in the body. For high doses of ionizing radiation (HD-IR) both immune-suppressive effects after whole body irradiation and possible immune activation during tumor therapy were observed. On the other hand, the effects of low doses of ionizing radiation (LD-IR) on the immune system are controversial and seem to show high variability among different individuals and species. There are reports revealing that protracted LD-IR can result in radioresistance. But immune-suppressive effects of chronic LD-IR are also reported, including the killing or sensitizing of certain cell types. This article shall review the current knowledge of radiation-induced effects on the immune system, paying special attention to the interaction of DCs and T cells.

1 November 2014 in Biochemical Pharmacology
Verified
Journal Article
Closed access
MHMaria Haustein
Maria Haustein
RRRobert Ramer
Robert Ramer
MLMichael Linnebacher
Michael Linnebacher
KMKatrin Manda
Katrin Manda
BHBurkhard Hinz
Burkhard Hinz

1 January 2012 in Frontiers in Oncology
Verified
Journal Article
Open access
Franz RödelFranz Rödel
Franz Rödel
Benjamin FreyBenjamin Frey
Benjamin Frey
KMKatrin Manda
Katrin Manda
GHGuido Hildebrandt
Guido Hildebrandt
SHStephanie Hehlgans
Stephanie Hehlgans
CRClaus Rödel
Claus Rödel
Inflammatory diseases are the result of complex and pathologically unbalanced multicellular interactions. For decades, low-dose X-irradiation therapy (LD-RT) has been clinically documented to exert an anti-inflammatory effect on benign diseases and chronic degenerative disorders. By contrast, experimental studies to confirm the effectiveness and to reveal underlying cellular and molecular mechanisms are still at their early stages. During the last decade, however, the modulation of a multitude of immunological processes by LD-RT has been explored in vitro and in vivo. These include leukocyte/endothelial cell adhesion, adhesion molecule and cytokine/chemokine expression, apoptosis induction, and mononuclear/polymorphonuclear cell metabolism and activity. Interestingly, these mechanisms display comparable dose dependences and dose-effect relationships with a maximum effect in the range between 0.3 and 0.7 Gy, already empirically identified to be most effective in the clinical routine. This review summarizes data and models exploring the mechanisms underlying the immunomodulatory properties of LD-RT that may serve as a prerequisite for further systematic analyses to optimize low-dose irradiation procedures in future clinical practice.

1 September 2014 in Biochemical Pharmacology
Verified
Journal Article
Closed access
RRRobert Ramer
Robert Ramer
SFSascha Fischer
Sascha Fischer
MHMaria Haustein
Maria Haustein
KMKatrin Manda
Katrin Manda
BHBurkhard Hinz
Burkhard Hinz

1 May 2005 in Tetrahedron
Verified
Journal Article
Closed access
SCSabine Ciecholewski
Sabine Ciecholewski
EHElke Hammer
Elke Hammer
KMKatrin Manda
Katrin Manda
GBGopal Bose
Gopal Bose
VNVan T.H. Nguyen
Van T.H. Nguyen
FSFrieder Schauer
Frieder Schauer